Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Akeso Biopharma
Pharma
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
While AZ/Daiichi's Enhertu and Roche's Polivy earned national reimbursement in China, Gilead's Trodelvy and Pfizer's Besponsa didn't.
Angus Liu
Dec 4, 2024 12:52pm
ESMO, WCLC lung cancer data spark hope—and debate
Sep 27, 2024 8:58am
Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia
Sep 13, 2024 8:53am
Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study
Sep 8, 2024 11:30am
Daiichi, Akeso, Genscript and Legend— Fierce Pharma Asia
Jun 7, 2024 6:00am
Summit and Akeso deliver Keytruda-topping results in NSCLC
May 31, 2024 11:00am
